A dangerous dose of deception, Pg9

Key Highlights:

• A large-scale counterfeit drug repackaging and re-labelling facility was uncovered in C.K. Tandya village, South Bengaluru district, Karnataka.
• The raid on August 18 led to the seizure of over 5,600 vials of counterfeit antibiotic injections, valued at approximately ₹4.91 crore.
• The racket involved procuring substandard or expired drugs, repackaging them with fake labels, and distributing them as genuine products.
• A Special Investigation Team (SIT) revealed the network spanned Karnataka, Himachal Pradesh, Haryana, Tamil Nadu, Maharashtra, and Telangana.
• Counterfeit critical-care and cancer medicines were supplied to over 90 hospitals and clinics, often at significant discounts.
• The owner of Krupa Healthcare, Veeresh Kumar Jain, was arrested for distributing these fake medicines.

Detailed Insights:

• The operation's discovery stemmed from an agricultural labourer's observation of medical waste, leading to police surveillance and a joint raid.
• The modus operandi involved procuring low-cost, substandard, or expired drugs and repackaging them to mimic genuine products for market entry.
• The distribution network utilized medical representatives to push these discounted fake medicines to private hospitals and medical centers across states.
• Patients with critical illnesses, including cancer, unknowingly received ineffective treatments, leading to severe health deterioration and financial distress.
• This incident underscores significant regulatory weaknesses, including inadequate drug inspection mechanisms and insufficient deterrents for offenders.
• Hospitals bear a legal and ethical responsibility under the Drugs and Cosmetics Act, 1940 to ensure responsible procurement and verify drug authenticity.
• Experts recommend direct drug procurement from manufacturers, stringent enforcement of quality standards, and collaborative efforts to safeguard the pharmaceutical supply chain.
• The Karnataka government has shared information on seized spurious drugs with central and state authorities, with the SIT actively pursuing the investigation.

Key Concepts Involved:

• Counterfeit Drugs: Illegally manufactured or mislabeled drugs that falsely represent their identity, source, or effectiveness.
• Spurious Drugs: Defined by the Drugs and Cosmetics Act, 1940, these are drugs that are not what they purport to be, or contain no active ingredient, or contain a different active ingredient.
• Pharmaceutical Supply Chain: The complex network involved in the production, distribution, and delivery of medicines from manufacturers to patients.
• Drugs and Cosmetics Act, 1940: The primary legislation in India regulating the import, manufacture, distribution, and sale of drugs and cosmetics.